Jiangsu Ningshangyou International Trade Co., Ltd – Trademark Portfolio
Entity Type: 99
Jiangsu Ningshangyou International Trade Co., Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 15 (Musical Instruments) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include EYEBODCARE. The owner is based in Suqian Jiangsu.
East side Of Guangzhou Road
Longhe Town, Sucheng District
Suqian Jiangsu 223832 , CN
Showing of trademarks Trademarks
Trademark Classifications
Jiangsu Ningshangyou International Trade Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Jiangsu Ningshangyou International Trade Co., Ltd have?
Jiangsu Ningshangyou International Trade Co., Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Jiangsu Ningshangyou International Trade Co., Ltd file in?
Jiangsu Ningshangyou International Trade Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 15 (Musical Instruments). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Jiangsu Ningshangyou International Trade Co., Ltd's most well-known trademarks?
Jiangsu Ningshangyou International Trade Co., Ltd's registered trademark portfolio includes well-known marks such as EYEBODCARE. These are among 1 currently registered trademark in the portfolio.
What is Jiangsu Ningshangyou International Trade Co., Ltd's trademark registration success rate?
Jiangsu Ningshangyou International Trade Co., Ltd has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.